Thyroid gland follicular carcinoma
MONDO:0005034A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland. The nuclear features which characterize the thyroid gland papillary carcinoma are absent. Radiation exposure is a risk factor and it comprises approximately 10% to 15% of thyroid cancers. Clinically, it usually presents as a solitary mass in the thyroid gland. It is generally unifocal and thickly encapsulated and shows invasion of the capsule or the vessels. Diagnostic procedures include thyroid ultrasound and fine needle biopsy.
Also known as: follicular cancer of the thyroid, follicular cancer of the thyroid gland, follicular cancer of thyroid, follicular cancer of thyroid gland, thyroid gland follicular cancer, well-differentiated follicular carcinoma, carcinoma of thyroid follicle, carcinoma, follicular cell, malignant
2830 clinical trials for this condition and its sub-types, 20 tagged with Thyroid gland follicular carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Thyroid gland follicular carcinoma
-
Medullary thyroid gland carcinoma 42 trials · 53 incl. sub-types
1 sub-type
- Familial medullary thyroid carcinoma 23 trials
-
Thyroid Hurthle cell carcinoma 11 trials
-
Thyroid cancer, nonmedullary, 2 4 trials
-
Thyroid cancer, nonmedullary, 4 0 trials
-
Thyroid cancer, nonmedullary, 5 0 trials
-
Trabecular follicular adenocarcinoma 0 trials
-
Immunotherapy combo tested for tough thyroid cancers
Disease control Stopped earlyThis phase II trial tested two immunotherapy drugs, durvalumab and tremelimumab, in 79 patients with advanced thyroid cancer that had progressed despite treatment. The goal was to see if the combination could slow or stop cancer growth. The study was terminated early, so the full…
Phase 2 • Sponsor: Grupo Espanol de Tumores Neuroendocrinos • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
A radioactive clue that could spare thousands from thyroid surgery
Diagnosis Stopped earlyThis trial tests whether a special imaging scan using a small amount of radioactive iodine (iodine-123) can tell the difference between benign and cancerous thyroid nodules before surgery. Currently, biopsy alone can't always make that call, so many people undergo surgery just to…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Aug 13, 2026 00:00 UTC